SCHMIDT ERIC THOMAS 4
4 · RELMADA THERAPEUTICS, INC. · Filed Dec 21, 2021
Insider Transaction Report
Form 4
SCHMIDT ERIC THOMAS
Director
Transactions
- Award
Stock Option (right to buy)
2021-12-17+58,765→ 58,765 totalExercise: $19.03From: 2022-03-17Exp: 2031-12-17→ Common Stock (58,765 underlying)
Footnotes (1)
- [F1]The option vests in 16 equal quarterly installments commencing on March 17, 2022.